Nimodipine Injection 10mg/50ml

Nimodipine Injection 10mg/50ml: What the Published Guidance Says

The resuscitation, antidote and critical-care injectables that a functioning emergency department cannot run without — most of them named directly on the WHO Model List.

Nimodipine Injection 10mg/50ml is specified against its own monograph, pack size and market registration, so the guidance below is worth reading together with the Emergency & Critical Care range overview.

• Specific antidotes The Model List names calcium gluconate and acetylcysteine among specific antidotes to poisoning. Acetylcysteine is the established antidote in paracetamol overdose; calcium gluconate is also the antidote administered for magnesium sulfate overdose in obstetric care. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
• Pre-operative and emergency antimuscarinics Atropine appears twice on the Model List — as a pre-operative medication at 400 micrograms/mL and 1 mg/mL (sulfate) in 1 mL ampoule or vial, and among specific antidotes. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
• Anaphylaxis and acute allergy The Model List places epinephrine (adrenaline) among the medicines used in anaphylaxis, and carries dexamethasone injection 4 mg/mL in 1 mL ampoule as disodium phosphate salt for both antiallergic use and palliative care, as well as in the antiemetic section. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)

These points are quoted because they shape how Nimodipine Injection 10mg/50ml is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.

Nimodipine Injection 10mg/50ml — Supply Parameters

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Heparin Sodium Injection 2mL:5000IU, Citicoline Injection 2ml:250mg Ampoule, Aceglutamide Injection 100mg/5mL, Dobutamine Injection 12.5mg/mL 2mL, Diphenhydramine Injection 50mg/mL 2mL, Dexamethasone Injection 8mg/2mL, Acetylcysteine Injection 1g/5mL, Phentolamine Injection 10mg/1mL.

Quality Control, Pharmacopoeial Standards & Documentation

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Nimodipine Injection 10mg/50ml is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

A typical release panel for this presentation covers:

• Testing for description and identification
• Testing for assay of the active substance
• Testing for related substances and impurities
• Testing for dissolution or release profile (solid oral forms)
• Testing for uniformity of dosage units
• Testing for water content and pH where applicable

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Packaging, Labelling & Export

• Pack size: 50mL sterile glass ampoule or vial (with rubber stopper and aluminum seal). Non-standard pack sizes can be quoted against your artwork.
• Storage: Store below 25°C, protected from light. Do not freeze. Keep ampoules/vials in outer carton until use..
• Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
• Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
• Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Registration, Dossier & Tender Support

Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.

• CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
• Site Master File and GMP certificate for the manufacturing workshops.
• Method validation, stability protocol and the shelf-life justification for the marketed pack.
• Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
• Tender and framework documentation, including pre-qualification questionnaires and sample logistics.

This page describes Nimodipine Injection 10mg/50ml as a product of the emergency and critical-care injectables named in the WHO Model List family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.

Related Emergency & Critical Care Products

• Heparin Sodium Injection 2mL:5000IU — 5000IU
• Citicoline Injection 2ml:250mg Ampoule — 250mg/2mL
• Aceglutamide Injection 100mg/5mL — 100mg/5mL
• Dobutamine Injection 12.5mg/mL 2mL — 12.5mg/mL
• Diphenhydramine Injection 50mg/mL 2mL — 50mg/mL
• Dexamethasone Injection 8mg/2mL — 8mg/2mL

Browse the full Emergency & Critical Care range; all Injectables; the complete product catalogue.